Abstract
B6AF1 anti-B10.D2 ascites fluid was separated in highly purified IgG1 and IgG2 alloantibodies, which were concentrated to yield similar specific antibody activities on the basis of two-stage lymphocytotoxicity. Their similar specific activities were confirmed by flow cytometric analysis. When tested for enhancement of B10.D2 skin, grafted onto B6JAF1 recipients, and for the opsonization of 51Cr-labelled B10.D2 leukocytes, IgG1 antibodies were as effective as the IgG2 preparation. Therefore IgG1 and IgG2 antibodies have similar enhancing capacities. The close correlation with their opsonizing effect supports the hypothesis that interaction of the Fc-part of enhancing alloantibody with Fc-receptor bearing cells is involved in the induction of enhancement.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
